Haleos Labs schedules board meeting for May 29

0 min read     Updated on 22 May 2026, 10:38 PM
scanx
Reviewed by
Anirudha BScanX News Team
AI Summary

Haleos Labs Limited has called a board meeting for May 29, 2026, to approve the financial results for FY26 under Regulation 29.

powered bylight_fuzz_icon
41015293

*this image is generated using AI for illustrative purposes only.

Haleos Labs Limited has scheduled a board meeting to discuss its financial performance for the upcoming fiscal period. The meeting is set to take place on May 29, 2026.

Agenda for the Meeting

The primary purpose of the meeting is to consider and approve the financial results for FY26. This proceeding is conducted in accordance with the requirements of Regulation 29.

Regulatory Compliance

The intimation of this meeting aligns with the company's commitment to maintaining transparency with its shareholders and regulatory bodies. The board will review the necessary financial statements and documentation required for the period ending March 31, 2026.

Historical Stock Returns for Haleos

1 Day5 Days1 Month6 Months1 Year5 Years
-0.26%+9.28%+19.58%+20.26%+22.03%+176.94%

How might Haleos Labs Limited's FY26 financial results compare to industry peers, and what key performance metrics will investors be watching most closely?

Will the board meeting on May 29, 2026 also address any dividend announcements or capital allocation strategies alongside the FY26 results?

What potential strategic initiatives or business expansions could Haleos Labs Limited announce following the approval of its FY26 financial results?

Haleos Labs Postal Ballot Result: Shareholders Approve Corporate Guarantee with 99.99% Votes

2 min read     Updated on 02 May 2026, 09:55 PM
scanx
Reviewed by
Jubin VScanX News Team
AI Summary

Haleos Labs Limited successfully concluded its postal ballot process with shareholders overwhelmingly approving the Material Related Party Transaction involving corporate guarantee to RBL Bank. The resolution received 1,05,592 votes in favour out of 1,05,600 total votes polled, representing 99.9924% approval rate. The transaction secures External Corporate Borrowings facility for subsidiary Mahi Drugs Private Limited, demonstrating strong shareholder confidence in the company's strategic decisions.

powered bylight_fuzz_icon
39138758

*this image is generated using AI for illustrative purposes only.

Haleos Labs Limited has successfully concluded its postal ballot process for seeking shareholder approval on Material Related Party Transactions involving the issuance of a corporate guarantee to RBL Bank. The resolution was passed on April 29, 2026, securing the External Corporate Borrowings facility availed by Mahi Drugs Private Limited, a subsidiary of the company.

Overwhelming Shareholder Support

The postal ballot results demonstrated exceptional shareholder confidence in the proposed transaction. The voting process was conducted exclusively through e-voting from March 31, 2026, to April 29, 2026, with Mr. C. Sudhir Babu of CSB Associates serving as the scrutinizer.

Voting Results: Details
Total Votes Polled: 1,05,600
Votes in Favour: 1,05,592 (99.9924%)
Votes Against: 8 (0.0076%)
Outstanding Shares Representation: 3.4929%

Category-wise Voting Breakdown

The detailed voting analysis reveals strong support across all shareholder categories. Public institutions showed unanimous support, while public non-institutions demonstrated near-complete approval for the resolution.

Category: Shares Held Votes Polled Votes in Favour Votes Against % in Favour
Promoter and Promoter Group: 21,79,976 - - - -
Public – Institutions: 8,932 8,932 8,932 - 100.0000%
Public – Non-Institutions: 8,34,379 96,668 96,660 8 99.9917%
Grand Total: 30,23,287 1,05,600 1,05,592 8 99.9924%

Resolution and Transaction Details

The Ordinary Resolution sought approval for the issuance of a corporate guarantee in favour of RBL Bank to secure the External Corporate Borrowings facility availed by Mahi Drugs Private Limited. Members holding equity shares as of the cut-off date of March 27, 2026, were entitled to vote on the proposed resolution. The Promoter and Promoter Group were interested parties in this agenda resolution.

Scrutinizer's Confirmation

Mr. C. Sudhir Babu, Practicing Company Secretary from CSB Associates, confirmed that the e-voting process was conducted in a fair and transparent manner. The company appointed Central Depository Services Limited (CDSL) as the agency for providing the e-voting facility. According to the scrutinizer's report, 68 members voted in favour while 3 members voted against the resolution, with no invalid votes recorded during the process.

Regulatory Compliance

The company has fulfilled all regulatory requirements under Regulation 30 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015. The results have been uploaded on the company's website at www.haleoslabs.com and on Central Depository Services (India) Limited's website at www.cdslindia.com . The scrutinizer's report has been submitted to the Managing Director, and all relevant records relating to e-voting will remain in safe custody until the minutes are signed and approved.

Historical Stock Returns for Haleos

1 Day5 Days1 Month6 Months1 Year5 Years
-0.26%+9.28%+19.58%+20.26%+22.03%+176.94%

What specific expansion or operational initiatives will Mahi Drugs Private Limited pursue with the RBL Bank borrowing facility?

How might this corporate guarantee arrangement affect Haleos Labs' debt capacity and credit rating in future financing decisions?

Will Haleos Labs consider similar guarantee structures for other subsidiaries to support their growth strategies?

More News on Haleos

1 Year Returns:+22.03%